echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Novavax and SII are authorized for emergency use of vaccines in India

    Novavax and SII are authorized for emergency use of vaccines in India

    • Last Update: 2022-01-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 29, Novavax and SII announced that the Drug Administration of India (DCGI) has granted an emergency use authorization (EUA) to Novavax for the recombinant nanoparticle protein new coronary pneumonia vaccine based on Matrix-M™ adjuvant


    Since the refrigeration standard for storing vaccines is 2 degrees Celsius to 8 degrees Celsius, the existing vaccine supply chain can be used for transportation and storage, thereby increasing the possibility of providing vaccines to remote areas


    The Novavax/SII vaccine has recently received emergency use authorization (EUA) in Indonesia and the Philippines, and has been included in the World Health Organization (WHO) Emergency Use List (EUL)


    Original English: https://ir.


    https://ir.
    novavax.
    com/2021-12-28-Novavax-and-Serum-Institute-of-India-Receive-Emergency-Use-Authorization-for-COVID-19-Vaccine-in-India
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.